DarioHealth to Report Fourth Quarter and Full Year 2020 Results on Tuesday, March 9
DarioHealth Corp. (Nasdaq: DRIO) will announce its financial results for Q4 and the full year ended December 31, 2020, on March 9, 2021, at 8:30 am Eastern Time. The conference call will feature leadership including CEO Erez Raphael and CFO Zvi Ben-David. Participants are encouraged to join 10 minutes early. A replay will be available two hours post-call until April 9, 2021. DarioHealth focuses on digital therapeutics, providing evidence-based interventions for those with chronic conditions, including diabetes, through its MyDario™ app.
- None.
- None.
NEW YORK, March 1, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the fourth quarter and full year ended December 31, 2020 on Tuesday, March 9, 2021, and host a conference call and webcast at 8:30 am Eastern Time.
Erez Raphael, Chief Executive Officer, Rick Anderson, President and General Manager of North America, and Zvi Ben-David, Chief Financial Officer, will host the call.
Conference Call Details
Date: Tuesday, March 9, 8:30 am EDT
Dial-in Number: 877-451-6152
International Dial-in: 201-389-0879
Conference ID: DarioHealth Fourth Quarter 2020 and Annual Results Call
Webcast: http://public.viavid.com/index.php?id=143705
Participants are asked to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through April 9, 2021. To listen to the replay, dial 844-512-2921 (domestic) or 412-317-6671 (international) and use replay passcode 13716928. The webcast archive will be available for two months.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Our cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™ mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, For more information, visit https://www.dariohealth.com/.
DarioHealth Corporate Contact:
Suzanne Bedell
VP Marketing
suzanne@dariohealth.com
+1-347-767-4220
Investor Relations Contact:
Chuck Padala
chuck@lifesciadvisors.com
+1-646-627-8390
Media Contact:
Natalie Joslin
dariohealth@mergeworld.com
+1 301-233-7907
View original content to download multimedia:http://www.prnewswire.com/news-releases/dariohealth-to-report-fourth-quarter-and-full-year-2020-results-on-tuesday-march-9-301237221.html
SOURCE DarioHealth Corp.
FAQ
What date will DarioHealth report its fourth quarter and full year 2020 financial results?
What time is the DarioHealth conference call on March 9, 2021?
Who will be hosting the DarioHealth conference call?
How can I access the DarioHealth conference call?
Will there be a replay available for the DarioHealth conference call?
